Immunohistochemical analyses of surgically resected samples showed that high expression of MGAT5 appears to be involved in the malignant potential (lymph vascular space involvement) of endometrial and mucinous ovarian cancer [53, 54], but high levels of MGAT5 are also related to a low malignant potential and good prognosis for patients with bladder cancer [55]. This evidence concerns the gene MGAT5 and urinary bladder cancer.